<?xml version="1.0" encoding="UTF-8"?>
<ref id="B42-marinedrugs-17-00374" class="ref">
 <label class="label">42.</label>
 <element-citation publication-type="journal" class="element-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Darwesh</surname>
    <given-names class="given-names">A.M.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Sosnowski</surname>
    <given-names class="given-names">D.K.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Lee</surname>
    <given-names class="given-names">T.Y.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Keshavarz-Bahaghighat</surname>
    <given-names class="given-names">H.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Seubert</surname>
    <given-names class="given-names">J.M.</given-names>
   </name>
  </person-group>
  <article-title class="article-title">Insights into the cardioprotective properties of n-3 PUFAs against ischemic heart disease via modulation of the innate immune system</article-title>
  <source class="source">Chem. Biol. Interact.</source>
  <year class="year">2019</year>
  <volume class="volume">308</volume>
  <fpage class="fpage">20</fpage>
  <lpage class="lpage">44</lpage>
  <pub-id pub-id-type="doi" class="pub-id">10.1016/j.cbi.2019.04.037</pub-id>
  <pub-id pub-id-type="pmid" class="pub-id">31067438</pub-id>
 </element-citation>
</ref>
